Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. BERLIN — Patients with a highly aggressive form of breast cancer will likely have new treatment options for the first time in years after AstraZeneca and Gilead Sciences both presented successful trial results here Sunday, dual achievements that will also leave …
Read More »
Three large drug companies shared new study results this week that point to more progress in breast cancer treatment. The news came during the European Society for Medical Oncology meeting in Berlin and drew close attention from investors in the health sector. The three companies in focus are Gilead Sciences (GILD), AstraZeneca (AZN), and Roche Holding AG (RHHVF). Elevate Your …
Read More »Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump Reuters Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca Al Jazeera AstraZeneca makes deal with White House to lower drug prices NPR Trump strikes drug-pricing deal with pharma giant AstraZeneca MSNBC News Watch: Trump to give announcement on lowering drug prices The Hill Source link
Read More »
United States President Donald Trump has unveiled a second deal with a major pharmaceutical company to offer lower-cost prescription drugs direct to American consumers. This time, the agreement concerned AstraZeneca, a multinational based in the United Kingdom. Recommended Stories list of 3 itemsend of list Trump hosted the company’s chief executive, Pascal Soriot, in the Oval Office on Friday to …
Read More »Trump unveils drug price deal with AstraZeneca Axios AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs The Guardian Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca Al Jazeera AstraZeneca makes deal with White House to lower drug prices NPR Trump announces deal with AstraZeneca aimed at lowering drug prices CNN Source link
Read More »
AstraZeneca CEO Pascal Soriot shakes hands with President Trump in the Oval Office, as Health and Human Services Secretary Robert F. Kennedy Jr. looks on. Andrew Harnik/Getty Images hide caption toggle caption Andrew Harnik/Getty Images AstraZeneca became the second drugmaker to enter a deal with the Trump administration to offer lower prices to Medicaid and to offer some of its …
Read More »
U.S. President Donald Trump participates in a bilateral meeting with Finland’s President Alexander Stubb (not pictured), in the Oval office at the White House in Washington, D.C., U.S., Oct. 9, 2025. Nathan Howard | Reuters The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S. The …
Read More »Trump to announce drug-price deal with AstraZeneca The Washington Post Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports CNBC Watch live: Trump to give announcement on lowering drug prices The Hill Donald Trump Jr. could profit from ‘TrumpRx’ drug companies plan MSNBC News Donald Trump’s Big Pharma Showdown Ends with a Whimper The New Yorker Source link
Read More »Trump to Announce a Drug Pricing Deal With AstraZeneca The New York Times Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports CNBC Trump to announce another effort to lower drug prices on Friday CNN Donald Trump Jr. could profit from ‘TrumpRx’ drug companies plan MSNBC News Donald Trump’s Big Pharma Showdown Ends with a Whimper The New Yorker Source link
Read More »
President Donald Trump on Friday plans to announce an agreement with the multinational pharmaceutical company AstraZeneca to lower drug prices in the United States, according to a White House official. The deal, to be announced from the Oval Office in the afternoon, includes a “most-favored-nation” drug pricing model aimed at making prescriptions more affordable for low-income Americans, including those on …
Read More »